AGITG Trial news: The AGITG currently has fourteen studies open to recruitment and three studies in follow up.
The table below details the AGITG trials that are currently accruing patients.
| Recruited | Target | Recruitment Period (months) | Date of First Site Open (ANZ) | Number of Sites Open | |
| ACTICCA-1 | 22 | 50 | 36 | 25 July 2016 | 13 |
| ASCOLT | 414 | 460 | 48 | 18 June 2014 | 32 |
| ASCOLT – Global | 1502 | 1587 | |||
| DYNAMIC-III | 349 | 1000 | 54 | 09 October 2017 | 37 |
| DYNAMIC-Pancreas | 29 | 438 | 54 | 01 March 2019 | 20 |
| DYNAMIC-Rectal | 142 | 408 | 36 | 18 June 2018 | 30 |
| INTEGRATE II | 69 | 90 | 48 | 19 October 2016 | 27 |
| INTEGRATE II – Global | 193 | 350 | 43 | ||
| MASTERPLAN | 1 | 120 | 48 | 01 October 2019 | 4 |
| MONARCC | 21 | 80 | 24 | 20 June 2018 | 22 |
| NABNEC | 37 | 58 | 54 | 15 September 2016 | 16 |
| Neo-CREATE | 6 | 20 | 36 | 17 June 2019 | 4 |
| PALEO | 2 | 54 | 36 | 16 September 2019 | 1 |
| RENO | 20 | 250 | 36 | 21 January 2019 | 3 |
| SPAR | 48 | 222 | 48 | 13 April 2018 | 15 |
| TOP GEAR | 236 | 280 | 118 | 29 September 2009 | 20 |
| TOP GEAR – Global | 538 | 570 | 47 |
Recruitment figures are for Australian and New Zealand sites as at end May 2020.
Trial Results Lay Summaries (click on the links below):
ALaCaRT
ATTACHE
ATTAX-3
GAP
ICECREAM
INTEGRATE
TACTIC
TOP GEAR
CO.17
EORTC 62024
Advanced GIST